Immune Recognition of Glycolipids
Immune Recognition of Glycolipids
批准号:
7329680
负责人:
Luc Teyton
金额:
$53.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2013-03-31
关键词:
AddressAgonistAnti-Bacterial AgentsAntibacterial ResponseAntigen TargetingAntigen-Presenting CellsAntigensAutoimmunityBindingBiochemicalBiochemistryBiologicalCD1 AntigensCarrier ProteinsCellsCellular ImmunologyCellular biologyCeramidesChemicalsChemistryClassificationCollaborationsComplementComplexEffector CellElementsEvolutionFluorescence Resonance Energy TransferG(M2) Activator ProteinGalactosylceramidesGenetic PolymorphismGlycolipidsGoalsHeadHumanImmuneImmune systemIn VitroInflammationKnockout MiceKnowledgeLigand BindingLigandsLipid BindingLipidsLipoproteinsLysosomesMeasurementModificationMusMutagenesisNatureNumbersPathway interactionsPeptidesPhysiologyPopulationPrincipal InvestigatorProtein EngineeringProteinsPublicationsReactionRecombinant ProteinsRoleSAP-A ProteinShapesSolutionsStructureSurfaceSystemT-Cell ReceptorT-LymphocyteThermodynamicsThymus GlandTimeUrsidae FamilyVaccine AntigenWorkbasedesignexperienceextracellularimmunogenicin vivoisoglobotriaosylceramidelipid transfer proteinlipid transportoxidationparticleprogramsprotein expressionreceptorreconstitutionresearch studyresponseskillssuccesstraffickinguptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The project entitled "Immune recognition of glycolipids" fits into a collaborative Program Project by
addressing biochemical and structural questions that complement biological studies led by Dr.Bendelac, and
by using extensively chemical compounds developed in collaboration with Dr.Savage. Our 3 Specific Aims
will be: Lipid Transfer Proteins (LTPs). We will examine the contribution of saposins A through D,
Niemann-Pick type C-2 and GM2 activator protein in the shaping of the repertoire of lipids presented by CD1
molecules in professional antigen presenting cells. In vivo studies in knock-out mice will evaluate the
contribution of each protein in the selection of NKT cells as well as in anti-bacterial responses. In vitro
studies will attempt to reconstitute the complex situation of the lysosome where CD1 resides with a mixture
of small LTPs and a wide spectrum of glycolipids. Biophysical measurements and structural studies will also
attempt to understand the mechanisms of transfer of lipids between CD1 and LTPs using real time FRET
and SPR. Extracellular Lipid Transport and Uptake. Extracellular lipids are kept in solution by associating
with lipoproteins particles or lipid transport proteins. The delivery of immunogenic lipids, such as bacterial
lipids, follows some of the same trafficking pathways. We will determine which pathway are important for
known agonists of NKT cells such as a-galactosyl ceramide (a-GalCer) and bacterial glucuronyl ceramides.
The identification of transport proteins will be driven by the usage of biotinylated compounds and
biochemistry. Lipid uptake and trafficking to the lysosome will be determined by cell biology and the usage of
knock-out mice for surface receptors. The consequences of in vivo modifications, such as oxidation that
accompanies inflammation, will also be studied with respect to transport. Finally, we will attempt some of the
knowledge gained by this specific aim to devise new strategies for delivering lipid antigens in vivo.
Structural Studies of CD1 recognition by Va14 T cell receptors. We know from experience that this
approach is highly unpredictable but we also know that it is unlikely that a sustained effort will not deliver
some results. This approach has allowed us to determine important structures such as CD1 bound to a-
GalCer but more structures are required. The main goal of this aim is to understand the ability of Va14 TCRs
to recognize ligands as different as CD1-iGb3 and CD1.-a-GalCer. To attain this goal new protein
engineering is required and will be exposed in details. Strong preliminary results will help us in the design of
these experiments. Additional CD1-lipid structures studies will also be proposed to understand the influence
of acyl chain unsaturation and head group modifications. Finally, we will also carry the systematic
mutagenesis of the Va14 chain to understand the thermodynamics of the reaction Va14/CD1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular basis of glycan recognition by T and B cells
-
批准号:10549648
-
项目类别:
-
资助金额:$45.42万
-
财政年份:2023
-
负责人:Luc Teyton
-
依托单位:
Administrative Core
-
批准号:10549641
-
项目类别:
-
资助金额:$3.87万
-
财政年份:2023
-
负责人:Luc Teyton
-
依托单位:
Antibody Core
-
批准号:10549643
-
项目类别:
-
资助金额:$19.46万
-
财政年份:2023
-
负责人:Luc Teyton
-
依托单位:
Leveraging Human iPSC-derived beta-cells to Probe Antigen Specificity of Anti-islet Memory T Cells in T1D
-
批准号:10589556
-
项目类别:
-
资助金额:$76.25万
-
财政年份:2023
-
负责人:Luc Teyton
-
依托单位:
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
-
批准号:10549640
-
项目类别:
-
资助金额:$202.5万
-
财政年份:2023
-
负责人:Luc Teyton
-
依托单位:
Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines
-
批准号:10599324
-
项目类别:
-
资助金额:$67.81万
-
财政年份:2021
-
负责人:Luc Teyton
-
依托单位:
Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines
-
批准号:10218993
-
项目类别:
-
资助金额:$69.98万
-
财政年份:2021
-
负责人:Luc Teyton
-
依托单位:
Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines
-
批准号:10397167
-
项目类别:
-
资助金额:$67.81万
-
财政年份:2021
-
负责人:Luc Teyton
-
依托单位:
Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis
-
批准号:10362605
-
项目类别:
-
资助金额:$78.85万
-
财政年份:2019
-
负责人:Luc Teyton
-
依托单位:
Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis
-
批准号:9884757
-
项目类别:
-
资助金额:$78.9万
-
财政年份:2019
-
负责人:Luc Teyton
-
依托单位:
Increasing the Social Science Impact of Biomedical Research
-
批准号:10089675
-
项目类别:
-
资助金额:$3.41万
-
财政年份:2018
-
负责人:Luc Teyton
-
依托单位:
NRSA Training Core
-
批准号:10159336
-
项目类别:
-
资助金额:$22.24万
-
财政年份:2018
-
负责人:Luc Teyton
-
依托单位:
NRSA Training Core
-
批准号:10401472
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2018
-
负责人:Luc Teyton
-
依托单位:
Development of the Next Generation of Conjugate Vaccines
-
批准号:9750619
-
项目类别:
-
资助金额:$84.64万
-
财政年份:2018
-
负责人:Luc Teyton
-
依托单位:
Development of the Next Generation of Conjugate Vaccines
-
批准号:10176386
-
项目类别:
-
资助金额:$84.35万
-
财政年份:2018
-
负责人:Luc Teyton
-
依托单位:
BioMark
-
批准号:8446911
-
项目类别:
-
资助金额:$32.17万
-
财政年份:2013
-
负责人:Luc Teyton
-
依托单位:
Molecular Pharmacology of NKT Cell Agonists
-
批准号:8663832
-
项目类别:
-
资助金额:$71.78万
-
财政年份:2013
-
负责人:Luc Teyton
-
依托单位:
Molecular Pharmacology of NKT Cell Agonists
-
批准号:8577662
-
项目类别:
-
资助金额:$69.71万
-
财政年份:2013
-
负责人:Luc Teyton
-
依托单位:
Molecular Pharmacology of NKT Cell Agonists
-
批准号:8850805
-
项目类别:
-
资助金额:$71.78万
-
财政年份:2013
-
负责人:Luc Teyton
-
依托单位:
Molecular Pharmacology of NKT Cell Agonists
-
批准号:9065492
-
项目类别:
-
资助金额:$72.73万
-
财政年份:2013
-
负责人:Luc Teyton
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: